PX1 Research provides verified, high-purity Chonluten (L-glutamyl-L-aspartyl-L-glycine) for laboratory assays investigating respiratory epithelial tissue restoration. Manufactured in the USA and backed by lot-specific RP-HPLC and mass spectrometry analysis, our analytical-grade Chonluten supports rigorous preclinical protocols in bronchial mucosa renewal.
PX1 Research provides verified, high-purity Chonluten (L-glutamyl-L-aspartyl-L-glycine) for laboratory assays investigating respiratory epithelial tissue restoration. Manufactured in the USA and backed by lot-specific RP-HPLC and mass spectrometry analysis, our analytical-grade Chonluten supports rigorous preclinical protocols in bronchial mucosa renewal.
A reliable bronchial mucosa renewal Chonluten supplier must deliver synthetic short-chain peptides with certified chemical purity (>98%), precise amino acid sequences, and verified low endotoxin levels for reproducible in vitro and animal model assays. PX1 Research supplies USA-manufactured Chonluten (Glu-Asp-Gly) accompanied by lot-specific third-party COAs, RP-HPLC chromatograms, and mass spectrometry data to meet strict academic and industrial research standards.
Investigators examining mucosal barrier restoration, goblet cell kinetics, and ciliated epithelial repair require target peptides free from synthesis side-products or bacterial contaminants. As a specialized domestic supplier, PX1 Research maintains full batch traceability and fast dispatch from ISO 17025-compliant facilities to support uninterrupted workflow in respiratory science.
Chonluten is a synthetic tripeptide consisting of L-glutamic acid, L-aspartic acid, and L-glycine (sequence: H-Glu-Asp-Gly-OH). With a molecular weight of approximately 305.24 g/mol, this short-chain regulatory peptide belongs to the class of biomimetic sequence signaling molecules originally identified during research into organ-specific peptide bioregulators.
In cell culture models, short tripeptides enter cellular structures via active transport mechanisms or direct membrane permeation. Once intracellular, preclinical evidence suggests that Chonluten modulates gene expression profiles specifically within pulmonary fibroblasts and bronchial epithelial lineage cells.
To explore complementary sequence architectures in bioregulatory science, scientists frequently consult our comprehensive catalog of short-chain bioregulatory peptides alongside dedicated research literature.
Preclinical studies indicate that Chonluten plays a target-specific role in modulating chromatin structure and transcription factor binding within respiratory epithelial tissue. In vitro assays evaluating primary human bronchial epithelial cells (HBECs) demonstrate that exposure to Glu-Asp-Gly shifts gene expression toward homeostatic mucociliary differentiation rather than hyperplastic remodelling.
In rodent models of toxic inflammatory airway challenge (e.g., exposure to lipopolysaccharide or cigarette smoke condensate), administration of research-grade Chonluten resulted in reduced inflammatory cell infiltration within the bronchoalveolar lavage fluid (BALF). Downstream markers of oxidative stress, including malondialdehyde and myeloperoxidase, showed statistically significant declines following experimental administration.
Furthermore, animal models evaluating epithelial layer recovery after mechanical or chemical scraping suggest that Chonluten enhances tight-junction protein assembly—specifically zonula occludens-1 (ZO-1) and occludin—accelerating the restoration of mucosal barrier integrity across monolayer cultures.
When designing comparative research protocols for epithelial barrier maintenance and tissue renewal, investigators frequently benchmark Chonluten against other tissue-active sequences. Understanding differences in sequence length, organ specificity, and signaling cascades is critical for structuring control groups.
For respiratory-focused studies, Chonluten is most frequently compared with Bronchogen, a tetrapeptide (Ala-Glu-Asp-Leu) targeting similar bronchial structures, and Thymogen (Glu-Trp), which primarily modulates systemic and localized immune response pathways. While Chonluten demonstrates high specificity for mucosal gene transcription and epithelial cell survival, Bronchogen acts preferentially on connective tissue elements within the airway wall. For broader mucosal surface repair assays involving gastrointestinal or pulmonary epithelium, researchers often evaluate BPC-157 alongside tripeptide bioregulators due to its distinct angiogenic and growth factor upregulatory properties.
The integrity of respiratory tissue assays depends entirely on reagent purity. Trace impurities, such as truncated peptide fragments or leftover TFA (trifluoroacetic acid) counter-ions, can alter cell viability and skew cytokine quantification in ELISA assays.
PX1 Research subjects every batch of Chonluten to high-performance liquid chromatography (RP-HPLC) to confirm sequence purity exceeding 98.0%. Electrospray ionization mass spectrometry (ESI-MS) is performed simultaneously to confirm exact molecular mass and confirm the absence of adducts or missing amino acid residues.
Because bronchial epithelial cell cultures are exceptionally sensitive to endotoxins, PX1 Research measures endotoxin burden via chromogenic Limulus Amebocyte Lysate (LAL) testing. Every lot supplied meets a strict threshold of <0.01 EU/mg, ensuring that observed cellular responses are attributable solely to the synthetic peptide rather than pyrogenic contamination.
Chonluten is supplied as a lyophilized, sterile powder to preserve chemical stability during transit and long-term storage. For optimal shelf-life, unopened vials should be stored at -20°C or -80°C in a desiccated environment, shielded from direct light.
When reconstituting Chonluten for in vitro assays, researchers should use sterile, nuclease-free water or phosphate-buffered saline (PBS, pH 7.4). The peptide exhibits high solubility in aqueous buffer systems due to its hydrophilic glutamyl and aspartyl side chains.
To prevent freeze-thaw degradation, working solutions should be aliquoted into single-use microcentrifuge tubes immediately after reconstitution and stored at -20°C. Repeated temperature cycling can lead to peptide bond cleavage or aggregation over extended experimental timeframes.
Procuring research compounds from unverified overseas vendors exposes laboratories to risks including inconsistent potency, batch-to-batch variation, hidden fillers (such as mannitol or glycine bulk additives), and unreliable documentation. PX1 Research mitigates these risks by conducting synthesis and analytical testing within US-based, cGMP-compliant facilities.
Every shipment originates from our centralized warehouses in California or Arizona, guaranteeing rapid domestic transit and eliminating customs holds. Each product vial features a batch-specific QR code linking directly to its verifiable, independent third-party Certificate of Analysis.
Laboratories managing ongoing grant projects or high-throughput screens can depend on PX1 Research for consistent lot-to-lot stoichiometry, ensuring that long-term cellular longitudinal studies yield reproducible data.
Academic laboratories, CROs, and biotechnology firms requiring sustained quantities of short-chain peptides can access custom supply arrangements through PX1 Research. We accommodate custom vial sizing, specialized packaging, and pre-analyzed bulk master batches to streamline large-scale preclinical trials.
To discuss bulk volume pricing, batch reservations, or institutional account setups, visit our wholesale portal or contact our technical support team for dedicated account management.
What is Chonluten used for in laboratory research?
Chonluten (Glu-Asp-Gly) is a synthetic tripeptide studied exclusively in preclinical and in vitro research models to investigate bronchial epithelial cell differentiation, mucosal repair mechanisms, cytokine modulation, and gene expression changes in respiratory tissues.
How does PX1 Research verify the quality of its Chonluten peptide?
Every lot of Chonluten undergoes third-party analytical testing, including RP-HPLC to verify chemical purity (>98%), ESI-MS to confirm molecular weight, and chromogenic LAL assays to ensure endotoxin levels remain below 0.01 EU/mg.
What is the primary difference between Chonluten and Bronchogen?
Chonluten is a tripeptide (Glu-Asp-Gly) primarily studied for its direct action on mucosal epithelial cell repair and gene expression. Bronchogen is a tetrapeptide (Ala-Glu-Asp-Leu) focused on bronchial wall matrix remodelling and structural tissue interactions.
What solvent is recommended for reconstituting Chonluten in vitro?
Chonluten is highly soluble in aqueous solutions. Researchers typically reconstitute the lyophilized powder in sterile nuclease-free water or sterile phosphate-buffered saline (PBS, pH 7.4) under a laminar flow hood.
How should lyophilized Chonluten be stored upon delivery?
Unopened lyophilized vials should be stored at -20°C or -80°C in a dry, dark environment. Upon reconstitution, liquid aliquots should be stored at -20°C to prevent freeze-thaw degradation.
Where is PX1 Research Chonluten manufactured and shipped from?
PX1 Research compounds are manufactured in domestic, cGMP-compliant US facilities and shipped directly from fulfillment centers located in California and Arizona.
Can Chonluten be ordered in bulk for high-throughput screening?
Yes, PX1 Research provides institutional packaging, bulk mass quantities, and dedicated batch reservations for research facilities. Inquiries can be submitted through our wholesale portal.
Is Chonluten approved for human therapeutic use or inhalation therapy?
No. Chonluten supplied by PX1 Research is strictly designated for in vitro, cellular, and animal preclinical research. It is not intended for human consumption, clinical use, or medical administration.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.